Previous 10 | Next 10 |
SAN DIEGO, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host its first-ever Strategy Day on Thursday, February 2nd, 2023, at the Nasdaq MarketSite in New York City, starting at 1:30 PM ET. The event will include presentations from members of th...
- Preliminary Q4 revenue expected to be between $8.1 and $8.4 million; 29% to 33% increase over Q4 2021 - Reached installed base of 240 systems as of YE 2022; 46% increase over YE 2021 - Achieved or exceeded all stated goals and milestones for the full year 2022 SAN DIEGO, Jan. 05, 2023 (...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips A bull-bear battle is starting to materialize in the stock market, and I believe that the struggle will intensify in early 2023. Bears believe that we’re heading for a steep recession and a horrible macro environment for...
Making specialized scientific instruments requires a lot of time spent on research and development (R&D). Still, businesses that succeed in creating killer laboratory hardware can sometimes rake in billions by enabling researchers to approach inquiries that they couldn't otherwise. Enter Bi...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Choosing the best drug stocks to buy can be dicey because drug stocks have disadvantages and advantages. On the negative side, you often have to wait many years for promising drugs to prove themselves in clinical trials. ...
Summary Bionano Genomics, Inc. is an engaging company operating in the genome mapping space. The company generated $7.2m of revenues from 217 installed bases in Q322. Performance of genetic testing developers, e.g., Illumina and PacBio, in 2022 has been poor. Bionano is making b...
Researchers from eight research institutes recommend OGM as first-line analysis for AML due to its ability to perform better and cost less than analysis with karyotyping, FISH, and CMA OGM identified pathogenic variants in 12% of cases that altered ELN risk-level or identified eli...
A scientific workshop will feature Dr. Rashmi Kanagal-Shamanna from the University of Texas MD Anderson Cancer Center delivering a presentation on the use of emerging technologies for prognostication and research into myeloid neoplasms Four scientific posters featuring results from ...
Hot Penny Stocks To Watch With The Stock Market Down Today The stock market is down today, but that doesn’t mean all stocks are getting dumped. In fact, in this article, we discuss a handful of bullish names trading higher in a sea of red. What’s helping them stay afloat? Big ne...
Acquisition adds isotachophoresis (ITP), a proprietary technology licensed exclusively from Stanford University and developed by Purigen Biosystems for isolation and purification of nucleic acids, to the arsenal of tools for potentially simplifying ultra high molecular weight (UHMW) DNA...
News, Short Squeeze, Breakout and More Instantly...
Bionano Genomics Inc. Company Name:
BNGO Stock Symbol:
NASDAQ Market:
Bionano Genomics Inc. Website:
A record 31 scientific presentations and posters at the 2024 European Society for Human Genetics (ESHG) Annual Conference and 8 scientific presentations and posters at the 2024 American Cytogenomics Conference ( ACC) will highlight the application of optical genome mapping...
SAN DIEGO, May 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics Inc. (“Bionano” or the “Company”) (NASDAQ: BNGO) today announced that it has completed a private placement of senior secured convertible debentures due May 24, 2026. The Company received gross proceeds of $18...